NATHAN ZASLER: Open Payments
NPI 1457656969 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$292 in 15 payments from 12 companies in 2025. Trend: 2023 $144 · 2024 $358 · 2025 $292
Food & beverage: $292
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $60 |
| Teva Pharmaceuticals USA, Inc. | 2 | $36 |
| ABBVIE INC. | 1 | $24 |
| Azurity Pharmaceuticals, Inc. | 1 | $23 |
| Dompe US, Inc. | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Lundbeck LLC | 1 | $20 |
| Vanda Pharmaceuticals Inc. | 1 | $19 |
| PFIZER INC. | 1 | $18 |
| Neurocrine BioSciences, Inc. | 1 | $18 |
Products named: CAPLYTA, REXULTI, QULIPTA, HORIZANT, OXERVATE, FANAPT, AUSTEDO XR, AJOVY.
Industry payments across VA — which companies pay providers there.
